ChemioCare Announces Addition of Chief Medical Advisor and Director
May 01, 2018 10:00 ET
|
ChemioCare
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a biotech company focused on transforming chemotherapy induced nausea and vomiting (CINV) outcomes...
Transdermal Patch Delivery Technologies Will Create New Blockbuster Drugs
March 25, 2014 07:30 ET
|
Lux Research
BOSTON, MA--(Marketwired - Mar 25, 2014) - Driven by convergence with other platform-enhancing technologies and shifting demographics, transdermal delivery of drugs (through the skin) is poised for...
Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs
April 14, 2009 08:00 ET
|
Vyteris, Inc.
FAIR LAWN, NJ--(Marketwire - April 14, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the
first FDA-approved active transdermal drug delivery system and a leader in
active transdermal drug...